Department of Neurology, Mayo Clinic, Rochester, MN.
Department of Psychiatry & Psychology Services, Mayo Clinic, Rochester, MN.
Am J Speech Lang Pathol. 2018 Nov 21;27(4):1303-1318. doi: 10.1044/2018_AJSLP-17-0227.
This case series details the clinical progression of patients with primary progressive apraxia of speech (PPAOS) to illustrate, using several methods and supplemental material examples, the changes that occur in speech and language functioning in this patient population.
Four patients who presented with PPAOS were followed between 5 and 6 years. Two patients had predominant articulatory abnormalities (termed phonetic PPAOS), 1 had predominant prosodic abnormalities (prosodic PPAOS), and 1 had relatively equal articulatory and prosodic abnormalities (mixed PPAOS). Detailed speech (including acoustics), language, neurologic, and neuropsychological data were collected.
At initial exam, the patients ranged from 60 to 77 years old, with presenting disease duration of 1.5-10 years. Although all patients presented with an isolated apraxia of speech, all developed varying degrees of aphasia and dysarthria. Patients with phonetic PPAOS developed relatively more severe aphasia than the other 2 patients. All patients eventually had severe functional communication limitations and required alternative or augmentative means of communication, although at varying times postonset of their initial speech problem. Two patients developed dysphagia, 3 showed mild-moderate Parkinsonism, and 2 developed depression. For all patients, simple temporal acoustic measurements documented slowed speech rate over time.
This case series demonstrates that patients who initially present with PPAOS may develop aphasia and dysarthria, cognitive and behavioral changes, and other neurologic signs. Whether these changes can be predicted by the perceptual characteristics of the apraxia of speech is yet to be determined. The detailed longitudinal profiles provide valuable clinical insight into the progression of disease in people with PPAOS.
本病例系列详细介绍了原发性进行性构音障碍(PPAOS)患者的临床进展,通过多种方法和补充材料示例来说明该患者人群的言语和语言功能变化。
对 4 名表现为 PPAOS 的患者进行了 5 至 6 年的随访。其中 2 名患者存在明显的发音异常(称为语音 PPAOS),1 名患者存在明显的韵律异常(韵律 PPAOS),1 名患者存在相对均等的发音和韵律异常(混合性 PPAOS)。收集了详细的言语(包括声学)、语言、神经和神经心理学数据。
在初次检查时,患者年龄在 60 至 77 岁之间,疾病呈现期为 1.5 至 10 年。尽管所有患者均表现为孤立性构音障碍,但均发展出不同程度的失语症和构音障碍。语音 PPAOS 患者比另外 2 名患者发展出更严重的失语症。尽管所有患者最终都出现严重的功能交流障碍,需要替代或补充的交流方式,但在他们初始言语问题出现后的不同时间。2 名患者出现吞咽困难,3 名患者表现出轻度至中度帕金森病,2 名患者出现抑郁。所有患者的简单时间声学测量均显示随着时间的推移,言语速度逐渐变慢。
本病例系列表明,最初表现为 PPAOS 的患者可能会发展出失语症和构音障碍、认知和行为改变以及其他神经体征。这些变化是否可以通过构音障碍的知觉特征来预测,还有待确定。详细的纵向分析为 PPAOS 患者疾病进展提供了有价值的临床见解。